|
|
Volumn 88, Issue 16, 1996, Pages 1100-1102
|
|
Raloxifene, retinoids, and lavender: 'Me too' tamoxifen alternatives under study
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ESTROGEN RECEPTOR;
IDOXIFENE;
RALOXIFENE;
RETINOID;
TAMOXIFEN;
TOREMIFENE;
APOPTOSIS;
BREAST CANCER;
CANCER SURVIVAL;
CARCINOGENICITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFECT;
DRUG EFFICACY;
ENDOMETRIUM CANCER;
FEMALE;
HUMAN;
NOTE;
PHASE 1 CLINICAL TRIAL;
PHASE 2 CLINICAL TRIAL;
|
|
EID: 0029810738
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/88.16.1100 Document Type: Note |
|
Times cited : (7)
|
|
References (0)
|